NCT06574425View on ClinicalTrials.gov

Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
Chronic Kidney DiseasesHemodialysis
Interventions
OTHER

long-term, high blood flow hemoadsorption therapy

Group 1 is the routine treatment group, Group 2 is the extended time group, and Group 3 is the extended time and increased blood flow group

Trial Locations (1)

100035

Nephrology Department of Beijing Jishuitan Hospital, Beijing

All Listed Sponsors
lead

Dongliang Zhang, MD

OTHER